Blum Holdings Inc (BLMH)
OTCMKTS: BLMH · Delayed Price · USD
0.799
+0.089 (12.52%)
Apr 18, 2024, 4:00 PM EDT - Market closed

Company Description

Blum Holdings, Inc. cultivates, produces, distributes, and retails medical and adult use cannabis products in California.

It also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities.

The company was formerly known as Unrivaled Brands, Inc. and changed its name to Blum Holdings, Inc. in January 2024.

Blum Holdings, Inc. was founded in 2010 and is based in Santa Ana, California.

Blum Holdings Inc
Country Canada
Founded 2010
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 151

Contact Details

Address:
3242 S. Halladay St., Suite 202
Santa Ana, California 92705
United States
Phone 888-909-5564

Stock Details

Ticker Symbol BLMH
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001451512
Employer ID 26-3062661
SIC Code 5900

Key Executives

Name Position
Sabas Carrillo Chief Executive Officer and Chairman
James Miller Chief Operating Officer and Director
Robert Baca Chief Legal Officer and Secretary
Hanna Gruntz Head of Sales
David Stogner Director of People
Tracy McCourt Chief Revenue Officer
Joe Gerlach Chief Cannabis Officer and Director for Korova

Latest SEC Filings

Date Type Title
Jan 16, 2024 15-12G Securities registration termination
Jan 16, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Jan 16, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Jan 16, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Jan 16, 2024 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
Jan 16, 2024 8-K Current Report
Dec 6, 2023 8-K Current Report
Nov 16, 2023 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Nov 16, 2023 8-K Current Report
Nov 15, 2023 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material